DalCor Pharmaceuticals

5 biotech CEOs on payers, investors and big bets
BioPharma Dive
Fri, 03/10/17 - 09:42 am
biotech
payers
investors
Gil Van Bokkelen
Athersys
Robert McNeil
DalCor Pharmaceuticals
Pierre Belichard
Enterome
Michael Metzger
Syndax
Spiro Rombotis
Cyclacel
Canadians hope $250 mln trial can revive failed Roche heart drug
Yahoo/Reuters
Tue, 06/9/15 - 11:59 am
Canada
Roche
drug trials
DalCor Pharmaceuticals
dalcetrapib